Jun-Li Luo (Junli Luo)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 13

Top Topics

Binding Protein

Ulcerative Colitis

Disease Activity

Endoplasmic Reticulum Stress

Top Venues

The Journal of experimental medicine

Journal of experimental & clinical cancer research : CR

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yangqing Sun, Qingqing Liu, Shangwei Zhong, Rui Wei, Jun-Li Luo
Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration. Cancers 16 (3) (2024)
Yangqing Sun, Qingqing Liu, Shangwei Zhong, Rui Wei, Jun-Li Luo
Triple-Negative Breast Cancer Intrinsic FTSJ1 Favors Tumor Progression and Attenuates CD8+ T Cell Infiltration. Cancers 16 (3) (2024)
Qingqing Liu, Yangqing Sun, Min Long, Xueyan Chen, Shangwei Zhong, Changhao Huang, Rui Wei, Jun-Li Luo
DDX5 Functions as a Tumor Suppressor in Tongue Cancer. Cancers 15 (24) (2023)
Qingqing Liu, Yangqing Sun, Min Long, Xueyan Chen, Shangwei Zhong, Changhao Huang, Rui Wei, Jun-Li Luo
DDX5 Functions as a Tumor Suppressor in Tongue Cancer. Cancers 15 (24) (2023)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Dapeng Wang, Jianbo Xiu, Jiangyue Zhao, Jun-Li Luo
miR-AB, a miRNA-based shRNA viral toolkit for multicolor-barcoded multiplex RNAi at a single-cell level. EMBO reports 23 (4) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Shangwei Zhong, Shoujiao Peng, Zihua Chen, Zhikang Chen, Jun-Li Luo
Choosing Kinase Inhibitors for Androgen Deprivation Therapy-Resistant Prostate Cancer. Pharmaceutics 14 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Ji-Hak Jeong, Shangwei Zhong, Fuzhuo Li, Changhao Huang, Xueyan Chen, Qingqing Liu, Shoujiao Peng, HaJeung Park, You Mie Lee, Jasreman Dhillon, Jun-Li Luo
Tumor-derived OBP2A promotes prostate cancer castration resistance. The Journal of experimental medicine 220 (3) (2022)
Shangwei Zhong, Ji-Hak Jeong, Changhao Huang, Xueyan Chen, Shohreh Iravani Dickinson, Jasreman Dhillon, Li Yang, Jun-Li Luo
Targeting INMT and interrupting its methylation pathway for the treatment of castration resistant prostate cancer. Journal of experimental & clinical cancer research : CR 40 (1) (2021)
Shangwei Zhong, Changhao Huang, Zhikang Chen, Zihua Chen, Jun-Li Luo
Targeting Inflammatory Signaling in Prostate Cancer Castration Resistance. Journal of clinical medicine 10 (21) (2021)